Role of complement system in patients with biopsy-proven immunoglobulin G4-related kidney disease

Rong Wang1, Dafeng He1, Lili Zhao2

  • 1National Clinical Research Center of Kidney Diseases, Jinling Clinical Medical College of Nanjing Medical University, Nanjing 210002, Jiangsu, China; Nephrology Department, Northern Jiangsu People's Hospital Affiliated to Yangzhou University, Yangzhou 225001, Jiangsu, China.

Human Pathology
|July 22, 2018
PubMed

Insights

Immunoglobulin G4-related kidney disease (IgG4-RKD) is rare, but complement system activation may play a role in its development. Lower C3 levels correlate with more severe IgG4-RKD indicators.

Area of Science:

  • Nephrology
  • Immunology
  • Pathology

Background:

  • Hypocomplementemia is frequently observed in immunoglobulin G4-related kidney disease (IgG4-RKD).
  • The specific role of the complement system in IgG4-RKD pathogenesis remains understudied.
  • IgG4-RKD is a rare renal disease characterized by IgG4-positive plasma cell infiltration.

Purpose of the Study:

  • To investigate the association between complement system activation, particularly C3 levels, and the clinical and pathological features of IgG4-RKD.
  • To explore the potential role of complement in the development and progression of IgG4-RKD.

Main Methods:

  • Retrospective analysis of 17 patients diagnosed with IgG4-RKD based on renal biopsy findings (January 2010-January 2018).
  • Patients were categorized into low-C3 (<0.8 μg/L) and normal-C3 (≥0.8 μg/L) groups.
  • Comparison of clinical parameters, serological markers, and renal histopathology between the two groups.

Main Results:

  • The low-C3 group exhibited lower C4 levels, higher IgG4 levels, increased rheumatoid factor positivity, and more severe storiform fibrosis compared to the normal-C3 group.
  • Serum C3 levels showed a negative correlation with serum IgG4, rheumatoid factor, renal C1q deposition, storiform fibrosis, interstitial fibrosis scores, and renal IgG4+ plasma cells.
  • Lower C3 levels were also associated with higher blood urea nitrogen levels at the latest follow-up.

Conclusions:

  • IgG4-RKD is a rare renal entity.
  • The complement system, particularly C3, appears to be involved in the pathogenesis of IgG4-RKD.
  • Complement activation may correlate with disease severity and specific histopathological findings in IgG4-RKD.

Related Concept Videos

Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
742
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
673
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
10.8K
Complementation Tests00:49

Complementation Tests

A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...
6.3K
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
481
Chronic Kidney Disease IV: Nursing Management01:18

Chronic Kidney Disease IV: Nursing Management

Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care​.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
401